Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroectodermal Tumors, Primitive 1Nasopharyngeal Carcinoma 1Medulloblastoma 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Glioma 1Glioblastoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Magnetic Resonance Spectroscopy 3thymoglobulin 1gallium Ga 68 dotatate 1fludarabine phosphate 1Valproic Acid 1Thiotepa 1Tacrolimus 1Stem Cell Transplantation 1Mycophenolic Acid 1Melphalan 1Hematopoietic Stem Cell Transplantation 1Gadolinium DTPA 1Etoposide 1Biopsy 1Antilymphocyte Serum 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Neuroectodermal Tumors, Primitive × Valproic Acid × Clear all
NCT01861990 2015-05-22

Valproic Acid in Childhood Progressive Brain Tumors

Medical University of South Carolina

Phase 1 Withdrawn
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Medulloblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡